| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Horikoshi M et al. | Punctate palmoplantar keratoderma with pigmentary lesions on the dorsa of feet and ankles: successful treatment with a combination of low-dose oral etretinate and topical calcipotriol. | 2004 | J. Dermatol. | pmid:15235186 |
| Yamamoto T et al. | Temporomandibular arthritis in a patient with psoriasis vulgaris under systemic etretinate therapy. | 2004 | Dermatology (Basel) | pmid:15237278 |
| De Graaf YG et al. | Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. | 2004 | Dermatol Surg | pmid:15061851 |
| Fujimura T et al. | CCR4 Expression by atypical T cells in systemic pilotropic lymphoma: its behavior under treatment with interferon gamma, topical PUVA and systemic retinoid. | 2004 | Dermatology (Basel) | pmid:15118371 |
| Suzuki K et al. | Localized Darier's disease of the scalp: successful treatment with oral etretinate. | 2004 | Dermatology (Basel) | pmid:14730246 |
| Launay F et al. | [Sneddon-Wilkinson disease. Four cases report]. | 2004 | Rev Med Interne | pmid:14744648 |
| Ikeda T et al. | The Vitamin A derivative etretinate improves skin sclerosis in patients with systemic sclerosis. | 2004 | J. Dermatol. Sci. | pmid:14757285 |
| Kobayashi H and Tagami H | Functional properties of the surface of the vermilion border of the lips are distinct from those of the facial skin. | 2004 | Br. J. Dermatol. | pmid:15030342 |
| Peñas PF et al. | Dermatologic treatment of cutaneous graft versus host disease. | 2004 | Am J Clin Dermatol | pmid:15663337 |
| Shimizu S et al. | Dramatic efficacy of oral aromatic retinoid in long-standing hypertrophic lupus erythematosus. | 2004 | Acta Derm. Venereol. | pmid:15844651 |
| Fraunfelder FW and Fraunfelder FT | Evidence for a probable causal relationship between tretinoin, acitretin, and etretinate and intracranial hypertension. | 2004 | J Neuroophthalmol | pmid:15348987 |
| Kato N et al. | Ferguson Smith type multiple keratoacanthomas and a keratoacanthoma centrifugum marginatum in a woman from Japan. | 2003 | J. Am. Acad. Dermatol. | pmid:14512932 |
| Lebwohl M et al. | Case studies in severe psoriasis: A clinical strategy. | 2003 | J Dermatolog Treat | pmid:14578096 |
| Foulc P et al. | Prognostic factors in Sézary syndrome: a study of 28 patients. | 2003 | Br. J. Dermatol. | pmid:14674891 |
| Corazza M et al. | Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine. | 2003 | Dermatology (Basel) | pmid:12771475 |
| Sahin MT et al. | Acrodermatitis continua of Hallopeau: was it an outcome of a surgical trauma or initially misdiagnosed as onychomycosis? | 2003 | J Eur Acad Dermatol Venereol | pmid:12705767 |
| Liu Y et al. | Sharing of the same embryogenic pathway in anorectal malformations and anterior sacral myelomeningocele formation. | 2003 | Pediatr. Surg. Int. | pmid:12682745 |
| Ogasawara Y et al. | A case of multiple keratoacanthoma centrifugum marginatum: response to oral etretinate. | 2003 | J. Am. Acad. Dermatol. | pmid:12582405 |
| Hu W et al. | Acrokeratoelastoidosis. | 2002 Jul-Aug | Pediatr Dermatol | pmid:12220276 |
| Schopf RE et al. | A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis. | 2002 | J. Invest. Dermatol. | pmid:12164939 |
| Kreiss C et al. | Severe cholestatic hepatitis in a patient taking acitretin. | 2002 | Am. J. Gastroenterol. | pmid:11922592 |
| Fujii K et al. | Short-term etretinate therapy for prurigo chronica multiformis. | 2002 | J. Dermatol. | pmid:11990249 |
| Budzyńska B et al. | The epidermis mitochondria ultrastructure evaluation of the etretinate-treated white rat. | 2002 | Ann Univ Mariae Curie Sklodowska Med | pmid:12898836 |
| Qu ZX et al. | Etretinate augments interferon beta-1b effects on suppressor cells in multiple sclerosis. | 2001 | Arch. Neurol. | pmid:11176940 |
| Krinitsyna YM et al. | Ultrastructural and biosynthetic characteristics of epidermal cells in patients with psoriasis treated with antiproliferative drugs. | 2001 | Bull. Exp. Biol. Med. | pmid:11713570 |
| Schmutz JL et al. | [Treatment with acitretin and alcohol drinking: a high risk combination]. | 2001 | Ann Dermatol Venereol | pmid:11908183 |
| Maier H and Hönigsmann H | Assessment of acitretin-treated female patients of childbearing age and subsequent risk of teratogenicity. | 2001 | Br. J. Dermatol. | pmid:11899131 |
| Górnicki A and Gutsze A | In vivo and in vitro influence of etretinate on erythrocyte membrane fluidity. | 2001 | Eur. J. Pharmacol. | pmid:11448476 |
| Magis NL et al. | The treatment of psoriasis with etretinate and acitretin: a follow up of actual use. | 2000 Oct-Nov | Eur J Dermatol | pmid:11056421 |
| Knights KM et al. | In vitro metabolism of acitretin by human liver microsomes: evidence of an acitretinoyl-coenzyme A thioester conjugate in the transesterification to etretinate. | 2000 | Biochem. Pharmacol. | pmid:10874125 |
| Hotard RS et al. | Sex-specific differences in the treatment of severe psoriasis. | 2000 | J. Am. Acad. Dermatol. | pmid:10727307 |
| Morishima T and Ochiai T | [Papillon-Lefèvre syndrome]. | 2000 | Ryoikibetsu Shokogun Shirizu | pmid:11212727 |
| Khatri ML et al. | Epidermolytic hyperkeratosis (bullous ichthyosis). | 2000 | J Eur Acad Dermatol Venereol | pmid:11204534 |
| Bowman PH and Hogan DJ | Ulcerated atrophic striae from etretinate. | 2000 | Cutis | pmid:10826097 |
| Siragusa M et al. | A new family with Papillon-Lefèvre syndrome: effectiveness of etretinate treatment. | 2000 | Cutis | pmid:10738634 |
| Jones G et al. | Interventions for psoriatic arthritis. | 2000 | Cochrane Database Syst Rev | pmid:10796328 |
| Kubota Y et al. | Congenital anomalies in mice induced by etretinate. | 2000 | Eur J Pediatr Surg | pmid:11034515 |
| Grønhøj Larsen F et al. | Acitretin is converted to etretinate only during concomitant alcohol intake. | 2000 | Br. J. Dermatol. | pmid:11122016 |
| Gijbels MJ et al. | Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm). | 2000 | Exp. Dermatol. | pmid:11016856 |
| Tanaka E et al. | [A case of intestinal Behçet's disease with abnormal ossification complicated by myelodysplastic syndrome, symptoms revealed after the perforation of ileum ulcer]. | 2000 | Ryumachi | pmid:11021176 |
| Hongcharu W et al. | Generalized lichen amyloidosis associated with chronic lichen planus. | 2000 | J. Am. Acad. Dermatol. | pmid:10901719 |
| Jones G et al. | Interventions for psoriatic arthritis. | 2000 | Cochrane Database Syst Rev | pmid:10908464 |
| Yasuda H et al. | Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review. | 2000 | Br. J. Dermatol. | pmid:10886149 |
| Kanoh H et al. | Granulomatous nodule on vocal cord possibly induced by etretinate therapy. | 2000 | Br. J. Dermatol. | pmid:10848772 |
| Hashimoto K et al. | Lamellar ichthyosis: response to etretinate with transglutaminase 1 recovery. | 2000 | Am J Dermatopathol | pmid:10871075 |
| Koide D et al. | Computerized reminders to monitor liver function to improve the use of etretinate. | 2000 | Int J Med Inform | pmid:10708252 |
| Koreeda T et al. | Inhibitory effect of retinoid on esophageal carcinogenesis in rats induced by N-nitroso-N-methylbutylamine in relation to cellular retinoic acid-binding protein. | 1999 Sep-Oct | Anticancer Res. | pmid:10628365 |
| Ozawa A et al. | Treatments of generalized pustular psoriasis: a multicenter study in Japan. | 1999 | J. Dermatol. | pmid:10209919 |
| Orfanos CE | Treatment of psoriasis with retinoids: present status. | 1999 | Cutis | pmid:10582161 |
| Brodell RT and Williams L | A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid. | 1999 | Postgrad Med | pmid:10608962 |
Etretinate
Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.
Cross Reference
Introduction
To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Etretinate?
Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Etretinate
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Etretinate?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Etretinate?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Etretinate?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Etretinate?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Etretinate?
There are no associated biomedical information in the current reference collection.